{
  "actions": [
    {
      "acted_at": "2008-07-08", 
      "committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2008-07-08", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "subcommittee": "Health", 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2008-07-09", 
      "in_committee": "House Committee on Energy and Commerce", 
      "in_subcommittee": "Health", 
      "references": [], 
      "text": "Subcommittee Consideration and Mark-up Session Held.", 
      "type": "action"
    }, 
    {
      "acted_at": "2008-07-09", 
      "in_committee": "House Committee on Energy and Commerce", 
      "in_subcommittee": "Health", 
      "references": [], 
      "text": "Forwarded by Subcommittee to Full Committee by Voice Vote .", 
      "type": "action"
    }, 
    {
      "acted_at": "2008-07-16", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "text": "Committee Consideration and Mark-up Session Held.", 
      "type": "action"
    }, 
    {
      "acted_at": "2008-07-16", 
      "in_committee": "House Committee on Energy and Commerce", 
      "references": [], 
      "status": "REPORTED", 
      "text": "Ordered to be Reported (Amended) by Voice Vote.", 
      "type": "calendar"
    }, 
    {
      "acted_at": "2008-07-30T13:49:00-04:00", 
      "references": [], 
      "text": "Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 110-805.", 
      "type": "action"
    }, 
    {
      "acted_at": "2008-07-30T13:49:00-04:00", 
      "calendar": "Union", 
      "number": "521", 
      "references": [], 
      "text": "Placed on the Union Calendar, Calendar No. 521.", 
      "type": "calendar", 
      "under": null
    }
  ], 
  "amendments": [], 
  "bill_id": "hr6433-110", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "markup", 
        "reporting"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral", 
        "markup", 
        "reporting"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }
  ], 
  "congress": "110", 
  "cosponsors": [
    {
      "district": "6", 
      "name": "Barton, Joe", 
      "sponsored_at": "2008-07-08", 
      "state": "TX", 
      "thomas_id": "00062", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "9", 
      "name": "Deal, Nathan", 
      "sponsored_at": "2008-07-08", 
      "state": "GA", 
      "thomas_id": "00277", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "1", 
      "name": "DeGette, Diana", 
      "sponsored_at": "2008-07-10", 
      "state": "CO", 
      "thomas_id": "01479", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "15", 
      "name": "Dingell, John D.", 
      "sponsored_at": "2008-07-08", 
      "state": "MI", 
      "thomas_id": "00299", 
      "title": "Rep", 
      "withdrawn_at": null
    }, 
    {
      "district": "10", 
      "name": "Towns, Edolphus", 
      "sponsored_at": "2008-07-08", 
      "state": "NY", 
      "thomas_id": "01165", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": true, 
    "active_at": "2008-07-09", 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2008-07-08", 
  "number": "6433", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to establish a program of fees relating to generic new animal drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Animal Generic Drug User Fee Act of 2008", 
  "sponsor": {
    "district": "6", 
    "name": "Pallone, Frank, Jr.", 
    "state": "NJ", 
    "thomas_id": "00887", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REPORTED", 
  "status_at": "2008-07-16", 
  "subjects": [
    "Administrative fees", 
    "Administrative procedure", 
    "Animals", 
    "Appropriations", 
    "Authorization", 
    "Commerce", 
    "Congress", 
    "Congressional reporting requirements", 
    "Department of Health and Human Services", 
    "Drug approvals", 
    "Drug industry", 
    "Economics and public finance", 
    "Electronic government information", 
    "Food and Drug Administration (FDA)", 
    "Generic drugs", 
    "Government operations and politics", 
    "Government publicity", 
    "Health", 
    "Law", 
    "Pharmaceutical research", 
    "Science, technology, communications", 
    "Sunset legislation", 
    "Veterinary medicine"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Reported to House amended", 
    "date": "2008-07-30", 
    "text": "Animal Generic Drug User Fee Act of 2008 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to assess and collect fees for an abbreviated application for a generic new animal drug, including application fees, product fees, and sponsor fees.Sets forth total revenue to be collected for each type of fee for FY2009-FY2013.Provides for fee adjustments. Requires the Secretary to establish such fees each fiscal year.Provides for fee waivers where the Secretary finds that the generic new animal drug is intended solely to provide for a minor use or minor species indication.Authorizes appropriations for FY2009-FY2013.Requires the Secretary to report to Congress and make publicly available information on: (1) progress toward the goal of expediting the generic new animal drug development process and the review of abbreviated applications for such drugs; and (2) the implementation of the authority for and use of generic new animal drug fees.Sets forth the process for developing recommendations to present to Congress for the review of abbreviated applications for generic new animal drugs after FY2013.Terminates the authority to assess and use generic new animal drug fees on October 1, 2013. Terminates reporting requirements on January 31, 2014."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Animal Generic Drug User Fee Act of 2008", 
      "type": "short"
    }, 
    {
      "as": "reported to house", 
      "is_for_portion": false, 
      "title": "Animal Generic Drug User Fee Act of 2008", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to establish a program of fees relating to generic new animal drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-19T22:00:05-04:00"
}